Advarra, Leading Provider of Life Sciences R&D Compliance and Technology Solutions, Secures Major Investment from Blackstone and CPP Investments - Seite 2

Anushka Sunder, a Senior Managing Director at Blackstone, said, “We are proud to back Advarra given its important role in enabling high-quality clinical R&D and helping its clients bring life-changing treatments to patients. Sustained innovation and scientific advancement in life sciences is one of our highest conviction investment themes across Blackstone. We are excited to partner with Gadi and the rest of the Advarra team to continue investing in talent, differentiated scientific expertise, customer-centric solutions, and innovative clinical trial technology to realize Advarra’s full potential in the years ahead.”

“Advarra has established a strong reputation in the industry and is well positioned to address the growing need for high-quality clinical research solutions, making it a good fit for our long-term investment strategy,” said Sam Blaichman, Managing Director, Head of North America, Direct Private Equity at CPP Investments. “We look forward to working with our partners and management to support the growth of the business in the coming years.”

“Since our acquisition in 2019, Gadi and the Advarra team have transformed the business into a leading provider of workflow solutions to make clinical trials safer, more efficient and ultimately, more successful,” commented David Golde, Managing Director at Genstar Capital. “It has been a pleasure driving this transformation with the Advarra team, and the company is on a very exciting trajectory to further its mission supporting the life sciences industry and the patients it serves. We wish Gadi, the entire management team, Blackstone, and CPP Investments the best success in driving Advarra’s next phase of strategic growth.”

Jefferies LLC is serving as lead financial advisor and Ropes & Gray LLP as legal counsel to Genstar and Advarra. BofA Securities acted as advisor in connection with the transaction. Simpson Thacher & Bartlett LLP is acting as legal counsel and Goldman Sachs & Co. LLC as financial advisor to Blackstone.

About Advarra
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.